{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:51:00Z","timestamp":1794019860178,"version":"4.8.0"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Glioblastoma remains the most aggressive and treatment-resistant brain malignancy, driven by genetic heterogeneity, metabolic plasticity, and an immunosuppressive tumor microenvironment (TME). Current therapies rely on inducing tumor cell death through DNA damage; however, glioma stem cells (GSCs) upregulate compensatory DNA repair pathways, promoting resistance and tumor recurrence. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, offers a novel therapeutic strategy to overcome therapy resistance by exploiting glioblastoma\u2019s metabolic vulnerabilities. Unlike conventional therapies, ferroptosis bypasses DNA repair mechanisms, making it particularly effective against therapy-resistant GSCs. It reduces tumor growth by triggering iron-catalyzed oxidative stress, disrupting lipid metabolism, and pushing glioblastoma cells beyond their oxidative threshold. However, resistance mechanisms to ferroptosis, including iron metabolism regulators (IREB2 and ferritinophagy), lipid peroxidation enzymes (ACSL4 and ALOXs), and protective pathways (cystine transporters and glutathione peroxidase 4), limit its therapeutic potential. Extracellular vesicle-mediated iron transfer further contributes to ferroptosis resistance, fostering chemoresistance and radio-resistance. Beyond direct tumor killing, ferroptosis modulates the TME by releasing damage-associated molecular patterns, inducing reactive oxygen species, stimulating CD8<jats:sup>+<\/jats:sup> T-cell activation, enhancing immune checkpoint blockade efficacy, and reprogramming tumor-associated macrophages toward an anti-tumor phenotype. Ferroptosis-based strategies, including glutathione peroxidase 4 inhibitors, nanoparticle-mediated iron delivery, and RNA-based therapies, offer promising avenues for enhancing glioblastoma treatment efficacy. This review highlights ferroptosis as a promising strategy for overcoming glioblastoma resistance by integrating it with chemotherapy, radiotherapy, and immunotherapy to enhance treatment efficacy. Given the complexity of glioblastoma, personalized ferroptosis-based approaches that address tumor heterogeneity, immune interactions, and metabolic adaptations are crucial for overcoming therapy resistance. Refining ferroptosis-targeted strategies by incorporating metabolic, immune, and genetic considerations can lead to more durable and effective therapies, ultimately transforming glioblastoma treatment and improving patient outcomes.<\/jats:p>","DOI":"10.1038\/s41420-025-02744-x","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:27:21Z","timestamp":1759843641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance"],"prefix":"10.1038","volume":"11","author":[{"given":"Shilpi","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iteeshree","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashis","family":"Barik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-5556","authenticated-orcid":false,"given":"Gatikrushna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2744_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","volume":"10","author":"S Singh","year":"2025","unstructured":"Singh S, Dey D, Barik D, Mohapatra I, Kim S, Sharma M, et al. Glioblastoma at the crossroads: current understanding and future therapeutic horizons. Signal Transduct Target Ther. 2025;10:213.","journal-title":"Signal Transduct Target Ther"},{"key":"2744_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, et al. Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharm Res. 2021;171:105780.","journal-title":"Pharm Res"},{"key":"2744_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","volume":"17","author":"H Lin","year":"2024","unstructured":"Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17:31.","journal-title":"J Hematol Oncol"},{"key":"2744_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","journal-title":"J Hematol Oncol"},{"key":"2744_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.","journal-title":"Signal Transduct Target Ther"},{"key":"2744_CR6","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.7150\/ijbs.96476","volume":"20","author":"Y Wei","year":"2024","unstructured":"Wei Y, Xu Y, Sun Q, Hong Y, Liang S, Jiang H, et al. Targeting ferroptosis opens new avenues in gliomas. Int J Biol Sci. 2024;20:4674\u201390.","journal-title":"Int J Biol Sci"},{"key":"2744_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.974156","volume":"9","author":"S Zhuo","year":"2022","unstructured":"Zhuo S, He G, Chen T, Li X, Liang Y, Wu W, et al. Emerging role of ferroptosis in glioblastoma: therapeutic opportunities and challenges. Front Mol Biosci. 2022;9:974156.","journal-title":"Front Mol Biosci"},{"key":"2744_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.993316","volume":"12","author":"J Shi","year":"2022","unstructured":"Shi J, Yang N, Han M, Qiu C. Emerging roles of ferroptosis in glioma. Front Oncol. 2022;12:993316.","journal-title":"Front Oncol"},{"key":"2744_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1346585","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Liu Y, Che S, Li X, Tang D, Lv S, et al. Deciphering the link: ferroptosis and its role in glioma. Front Immunol. 2024;15:1346585.","journal-title":"Front Immunol"},{"key":"2744_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51259-5","volume":"14","author":"X Zheng","year":"2024","unstructured":"Zheng X, Toyama T, Siu S, Kaneko T, Sugiura H, Yamashita S, et al. Selenoprotein P expression in glioblastoma as a regulator of ferroptosis sensitivity: preservation of GPX4 via the cycling-selenium storage. Sci Rep. 2024;14:682.","journal-title":"Sci Rep"},{"key":"2744_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-024-00472-x","volume":"18","author":"N Teferi","year":"2024","unstructured":"Teferi N, Ekanayake A, Owusu SB, Moninger TO, Sarkaria JN, Tivanski AV, et al. Glutathione peroxidase 4 overexpression induces anomalous subdiffusion and impairs glioblastoma cell growth. J Biol Eng. 2024;18:72.","journal-title":"J Biol Eng"},{"key":"2744_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/acs.biochem.0c00030","volume":"59","author":"K Hadian","year":"2020","unstructured":"Hadian K. Ferroptosis suppressor protein 1 (FSP1) and coenzyme Q10 cooperatively suppress ferroptosis. Biochemistry. 2020;59:637\u20138.","journal-title":"Biochemistry"},{"key":"2744_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41392-021-00656-7","volume":"6","author":"F Wang","year":"2021","unstructured":"Wang F, Min J. DHODH tangoing with GPX4 on the ferroptotic stage. Signal Transduct Target Ther. 2021;6:244.","journal-title":"Signal Transduct Target Ther"},{"key":"2744_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/13510002.2022.2046423","volume":"27","author":"B Zhang","year":"2022","unstructured":"Zhang B, Pan C, Feng C, Yan C, Yu Y, Chen Z, et al. Role of mitochondrial reactive oxygen species in homeostasis regulation. Redox Rep. 2022;27:45\u201352.","journal-title":"Redox Rep"},{"key":"2744_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.phrs.2015.06.013","volume":"100","author":"IS Okon","year":"2015","unstructured":"Okon IS, Zou M-H. Mitochondrial ROS and cancer drug resistance: Implications for therapy. Pharm Res. 2015;100:170\u20134.","journal-title":"Pharm Res"},{"key":"2744_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct Target Ther. 2023;8:1\u201324.","journal-title":"Signal Transduct Target Ther"},{"key":"2744_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2022.100058","volume":"103","author":"X Li","year":"2023","unstructured":"Li X, Xiong W, Wang Y, Li Y, Cheng X, Liu W. p53 Activates the lipoxygenase activity of ALOX15B via inhibiting SLC7A11 to induce ferroptosis in bladder cancer cells. Lab Invest. 2023;103:100058.","journal-title":"Lab Invest"},{"key":"2744_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110479","volume":"378","author":"H Li","year":"2023","unstructured":"Li H, Wang B, Wu S, Dong S, Jiang G, Huang Y, et al. Ferroptosis is involved in polymyxin B-induced acute kidney injury via activation of p53. Chem Biol Interact. 2023;378:110479.","journal-title":"Chem Biol Interact"},{"key":"2744_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73:354\u201363.e3.","journal-title":"Mol Cell"},{"key":"2744_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.133","volume":"8","author":"F Basit","year":"2017","unstructured":"Basit F, van Oppen LM, Sch\u00f6ckel L, Bossenbroek HM, van Emst-de Vries SE, Hermeling JC, et al. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells. Cell Death Dis. 2017;8:e2716.","journal-title":"Cell Death Dis"},{"key":"2744_CR21","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1158\/2159-8290.CD-20-1437","volume":"11","author":"F Puca","year":"2021","unstructured":"Puca F, Yu F, Bartolacci C, Pettazzoni P, Carugo A, Huang-Hobbs E, et al. Medium-Chain Acyl-CoA dehydrogenase protects mitochondria from lipid peroxidation in glioblastoma. Cancer Discov. 2021;11:2904\u201323.","journal-title":"Cancer Discov"},{"key":"2744_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/antiox5010007","volume":"5","author":"G Barrera","year":"2016","unstructured":"Barrera G, Gentile F, Pizzimenti S, Canuto RA, Daga M, Arcaro A, et al. Mitochondrial dysfunction in cancer and neurodegenerative diseases: spotlight on fatty acid oxidation and lipoperoxidation products. Antioxidants. 2016;5:7.","journal-title":"Antioxidants"},{"key":"2744_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.phrs.2018.09.008","volume":"138","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Karam C, Yi J, Zhang L, Li X, Yoon D, et al. ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression. Pharmacol Res. 2018;138:25\u201336.","journal-title":"Pharmacol Res"},{"key":"2744_CR24","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.3390\/ijms21093289","volume":"21","author":"HR Yun","year":"2020","unstructured":"Yun HR, Jo YH, Kim J, Shin Y, Kim SS, Choi TG. Roles of autophagy in oxidative stress. Int J Mol Sci. 2020;21:3289.","journal-title":"Int J Mol Sci"},{"key":"2744_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/bab.2104","volume":"69","author":"L Kma","year":"2022","unstructured":"Kma L, Baruah TJ. The interplay of ROS and the PI3K\/Akt pathway in autophagy regulation. Biotechnol Appl Biochem. 2022;69:248\u201364.","journal-title":"Biotechnol Appl Biochem"},{"key":"2744_CR26","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1080\/15548627.2020.1713640","volume":"16","author":"M Bernard","year":"2020","unstructured":"Bernard M, Yang B, Migneault F, Turgeon J, Dieud\u00e9 M, Olivier M-A, et al. Autophagy drives fibroblast senescence through MTORC2 regulation. Autophagy. 2020;16:2004\u201316.","journal-title":"Autophagy"},{"key":"2744_CR27","first-page":"99","volume":"71","author":"I \u010cepelak","year":"2020","unstructured":"\u010cepelak I, Dodig S, Dodig D\u010c. Ferroptosis: regulated cell death. Arh Hig Rada Toksikol. 2020;71:99\u2013109.","journal-title":"Arh Hig Rada Toksikol"},{"key":"2744_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.947530","volume":"12","author":"G Zhang","year":"2022","unstructured":"Zhang G, Fang Y, Li X, Zhang Z. Ferroptosis: a novel therapeutic strategy and mechanism of action in glioma. Front Oncol. 2022;12:947530.","journal-title":"Front Oncol"},{"key":"2744_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/medicina58020319","volume":"58","author":"A-O Mitre","year":"2022","unstructured":"Mitre A-O, Florian AI, Buruiana A, Boer A, Moldovan I, Soritau O, et al. Ferroptosis involvement in glioblastoma treatment. Medicina. 2022;58:319.","journal-title":"Medicina"},{"key":"2744_CR30","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1002\/jcp.30060","volume":"236","author":"H Chen","year":"2021","unstructured":"Chen H, Xu C, Yu Q, Zhong C, Peng Y, Chen J, et al. Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma. J Cell Physiol. 2021;236:2988\u20133000.","journal-title":"J Cell Physiol"},{"key":"2744_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"H Yan","year":"2021","unstructured":"Yan H, Zou T, Tuo Q, Xu S, Li H, Belaidi AA, et al. Ferroptosis: mechanisms and links with diseases. Sig Transduct Target Ther. 2021;6:1\u201316.","journal-title":"Sig Transduct Target Ther"},{"key":"2744_CR32","doi-asserted-by":"publisher","unstructured":"Xin Z, Xiang Y, Wang Q, Bai X, Meng D, Wu J, et al. Regulation of iron metabolism in ferroptosis: from mechanism research to clinical translation. J Pharm Anal. 2025;101304. https:\/\/doi.org\/10.1016\/j.jpha.2025.101304.","DOI":"10.1016\/j.jpha.2025.101304"},{"key":"2744_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116363","volume":"173","author":"F Khan","year":"2024","unstructured":"Khan F, Pandey P, Verma M, Ramniwas S, Lee D, Moon S, et al. Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy. Biomed Pharmacother. 2024;173:116363.","journal-title":"Biomed Pharmacother"},{"key":"2744_CR34","doi-asserted-by":"publisher","first-page":"267a","DOI":"10.1016\/j.bpj.2021.11.1429","volume":"121","author":"G Shenoy","year":"2022","unstructured":"Shenoy G, Kuhn M, Palsa K, Slagle-Webb B, Snyder AM, Khunsriraksakul C, et al. Cellular iron status influences cell motility in glioblastoma. Biophys J. 2022;121:267a.","journal-title":"Biophys J"},{"key":"2744_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149045","volume":"1840","author":"S Yeon Kim","year":"2024","unstructured":"Yeon Kim S, Tang M, Lu T, Chih SY, Li W. Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles. Brain Res. 2024;1840:149045.","journal-title":"Brain Res"},{"key":"2744_CR36","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41388-020-01622-3","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Kong Y, Ma Y, Ni S, Wikerholmen T, Xi K, et al. Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines. Oncogene. 2021;40:1425\u201339.","journal-title":"Oncogene"},{"key":"2744_CR37","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15136","volume":"11","author":"L Deng","year":"2023","unstructured":"Deng L, Zeng S, Yi Q, Song L. High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma. PeerJ. 2023;11:e15136.","journal-title":"PeerJ"},{"key":"2744_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","volume":"7","author":"Y Yu","year":"2021","unstructured":"Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021;7:193.","journal-title":"Cell Death Discov"},{"key":"2744_CR39","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/cells12050804","volume":"12","author":"MS Mortensen","year":"2023","unstructured":"Mortensen MS, Ruiz J, Watts JL. Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis. Cells. 2023;12:804.","journal-title":"Cells"},{"key":"2744_CR40","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.3390\/ijms241210021","volume":"24","author":"B Jia","year":"2023","unstructured":"Jia B, Li J, Song Y, Luo C. ACSL4-mediated ferroptosis and its potential role in central nervous system diseases and injuries. Int J Mol Sci. 2023;24:10021.","journal-title":"Int J Mol Sci"},{"key":"2744_CR41","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/cas.13380","volume":"108","author":"R Shintoku","year":"2017","unstructured":"Shintoku R, Takigawa Y, Yamada K, Kubota C, Yoshimoto Y, Takeuchi T, et al. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3. Cancer Sci. 2017;108:2187\u201394.","journal-title":"Cancer Sci"},{"key":"2744_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1535073","volume":"13","author":"S D\u2019Aprile","year":"2025","unstructured":"D\u2019Aprile S, Denaro S, Gervasi A, Vicario N, Parenti R. Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance. Front Cell Dev Biol. 2025;13:1535073.","journal-title":"Front Cell Dev Biol"},{"key":"2744_CR43","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s42003-024-07180-8","volume":"7","author":"X Yang","year":"2024","unstructured":"Yang X, Liu Y, Wang Z, Jin Y, Gu W. Ferroptosis as a new tool for tumor suppression through lipid peroxidation. Commun Biol. 2024;7:1475.","journal-title":"Commun Biol"},{"key":"2744_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.chembiol.2021.07.022","volume":"29","author":"D Yamane","year":"2022","unstructured":"Yamane D, Hayashi Y, Matsumoto M, Nakanishi H, Imagawa H, Kohara M, et al. FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication. Cell Chem Biol. 2022;29:799\u2013810.e4.","journal-title":"Cell Chem Biol"},{"key":"2744_CR45","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/10715762.2021.1962009","volume":"55","author":"C Bao","year":"2021","unstructured":"Bao C, Zhang J, Xian S-Y, Chen F. MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4. Free Radic Res. 2021;55:853\u201364.","journal-title":"Free Radic Res"},{"key":"2744_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00304-3","volume":"10","author":"X Yang","year":"2021","unstructured":"Yang X, Liu J, Wang C, Cheng KK, Xu H, Li Q, et al. miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities. Oncogenesis. 2021;10:15.","journal-title":"Oncogenesis"},{"key":"2744_CR47","doi-asserted-by":"publisher","first-page":"8100","DOI":"10.1002\/cam4.4320","volume":"10","author":"L Ye","year":"2021","unstructured":"Ye L, Xu Y, Wang L, Zhang C, Hu P, Tong S, et al. Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas. Cancer Med. 2021;10:8100\u201313.","journal-title":"Cancer Med"},{"key":"2744_CR48","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1101\/gad.334219.119","volume":"34","author":"D Venkatesh","year":"2020","unstructured":"Venkatesh D, O\u2019Brien NA, Zandkarimi F, Tong DR, Stokes ME, Dunn DE, et al. MDM2 and MDMX promote ferroptosis by PPAR\u03b1-mediated lipid remodeling. Genes Dev. 2020;34:526\u201343.","journal-title":"Genes Dev"},{"key":"2744_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbrc.2020.12.075","volume":"539","author":"K Hayashima","year":"2021","unstructured":"Hayashima K, Kimura I, Katoh H. Role of ferritinophagy in cystine deprivation-induced cell death in glioblastoma cells. Biochem Biophys Res Commun. 2021;539:56\u201363.","journal-title":"Biochem Biophys Res Commun"},{"key":"2744_CR50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620.","journal-title":"Protein Cell"},{"key":"2744_CR51","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.4149\/neo_2021_210327N410","volume":"68","author":"N Hu","year":"2021","unstructured":"Hu N, Hu W-H, Zhou S-L, Yang Z, Liang W-L, Yang R-Y, et al. SLC7A11 negatively associates with mismatch repair gene expression and endows glioblastoma cells sensitive to radiation under low glucose conditions. Neoplasma. 2021;68:1147\u201356.","journal-title":"Neoplasma"},{"key":"2744_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109874","volume":"78","author":"M Yamamoto","year":"2021","unstructured":"Yamamoto M, Teramoto K, Katoh H. Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11). Cell Signal. 2021;78:109874.","journal-title":"Cell Signal"},{"key":"2744_CR53","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1074\/jbc.RA119.012213","volume":"295","author":"I Yamaguchi","year":"2020","unstructured":"Yamaguchi I, Yoshimura SH, Katoh H. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine\/glutamate transporter xCT (SLC7A11). J Biol Chem. 2020;295:6936\u201345.","journal-title":"J Biol Chem"},{"key":"2744_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1227\/NEU.0b013e318276b2de","volume":"72","author":"S Takeuchi","year":"2013","unstructured":"Takeuchi S, Wada K, Toyooka T, Shinomiya N, Shimazaki H, Nakanishi K, et al. Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. Neurosurg. 2013;72:33\u201341.","journal-title":"Neurosurg"},{"key":"2744_CR55","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.3390\/cancers13246169","volume":"13","author":"RA Umans","year":"2021","unstructured":"Umans RA, Martin J, Harrigan ME, Patel DC, Chaunsali L, Roshandel A, et al. Transcriptional regulation of amino acid transport in glioblastoma multiforme. Cancers. 2021;13:6169.","journal-title":"Cancers"},{"key":"2744_CR56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334.","journal-title":"Cancer Cell"},{"key":"2744_CR57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, et al. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270\u20134.","journal-title":"Nature"},{"key":"2744_CR58","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1541-7786.MCR-16-0028","volume":"14","author":"MD Polewski","year":"2016","unstructured":"Polewski MD, Reveron-Thornton RF, Cherryholmes GA, Marinov GK, Cassady K, Aboody KS. Increased expression of system xc- in glioblastoma confers an altered metabolic state and temozolomide resistance. Mol Cancer Res. 2016;14:1229\u201342.","journal-title":"Mol Cancer Res"},{"key":"2744_CR59","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9:1673\u201385.","journal-title":"Cancer Discov"},{"key":"2744_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","volume":"3","author":"SJ Dixon","year":"2019","unstructured":"Dixon SJ, Stockwell BR. The hallmarks of ferroptosis. Annu Rev Cancer Biol. 2019;3:35\u201354.","journal-title":"Annu Rev Cancer Biol"},{"key":"2744_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201800311","volume":"19","author":"GC Forcina","year":"2019","unstructured":"Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19:e1800311.","journal-title":"Proteomics"},{"key":"2744_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0794-4","volume":"9","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zheng Y, Wang C, Liu Y. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis. 2018;9:753.","journal-title":"Cell Death Dis"},{"key":"2744_CR63","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1016\/S0021-9258(17)42703-7","volume":"259","author":"GF Seelig","year":"1984","unstructured":"Seelig GF, Simondsen RP, Meister A. Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. J Biol Chem. 1984;259:9345\u20137.","journal-title":"J Biol Chem"},{"key":"2744_CR64","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3892\/ol.2020.11980","volume":"20","author":"S Tan","year":"2020","unstructured":"Tan S, Hou X, Mei L. Dihydrotanshinone I inhibits human glioma cell proliferation via the activation of ferroptosis. Oncol Lett. 2020;20:122.","journal-title":"Oncol Lett"},{"key":"2744_CR65","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"2744_CR66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40170-021-00250-z","volume":"9","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Tao L, Zhou X, Zuo Z, Gong J, Liu X, et al. DHODH and cancer: promising prospects to be explored. Cancer Metab. 2021;9:22.","journal-title":"Cancer Metab"},{"key":"2744_CR67","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1038\/s41586-021-03820-9","volume":"596","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. Author Correction: DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;596:E13.","journal-title":"Nature"},{"key":"2744_CR68","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/03602530600971974","volume":"38","author":"DD Zhang","year":"2006","unstructured":"Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006;38:769\u201389.","journal-title":"Drug Metab Rev"},{"key":"2744_CR69","doi-asserted-by":"publisher","first-page":"9964","DOI":"10.1073\/pnas.1913633117","volume":"117","author":"D Yu","year":"2020","unstructured":"Yu D, Liu Y, Zhou Y, Ruiz-Rodado V, Larion M, Xu G, et al. Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism. Proc Natl Acad Sci USA. 2020;117:9964\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2744_CR70","doi-asserted-by":"publisher","first-page":"10247","DOI":"10.3390\/ijms221910247","volume":"22","author":"H-Y Chuang","year":"2021","unstructured":"Chuang H-Y, Hsu L-Y, Pan C-M, Pikatan NW, Yadav VK, Fong I-H, et al. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis. Int J Mol Sci. 2021;22:10247.","journal-title":"Int J Mol Sci"},{"key":"2744_CR71","doi-asserted-by":"publisher","first-page":"48081","DOI":"10.18632\/oncotarget.10129","volume":"7","author":"CRR Rocha","year":"2016","unstructured":"Rocha CRR, Kajitani GS, Quinet A, Fortunato RS, Menck CFM. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells. Oncotarget. 2016;7:48081\u201392.","journal-title":"Oncotarget"},{"key":"2744_CR72","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1080\/15548627.2018.1513758","volume":"14","author":"R Kang","year":"2018","unstructured":"Kang R, Zhu S, Zeh HJ, Klionsky DJ, Tang D. BECN1 is a new driver of ferroptosis. Autophagy. 2018;14:2173\u20135.","journal-title":"Autophagy"},{"key":"2744_CR73","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","volume":"28","author":"X Song","year":"2018","unstructured":"Song X, Zhu S, Chen P, Hou W, Wen Q, Liu J, et al. AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system Xc- activity. Curr Biol. 2018;28:2388\u201399.e5.","journal-title":"Curr Biol"},{"key":"2744_CR74","doi-asserted-by":"publisher","first-page":"386","DOI":"10.18632\/oncoscience.495","volume":"6","author":"F Lessard","year":"2019","unstructured":"Lessard F, Saint-Germain E, Mignacca L, Ferbeyre G. SOCS1: phosphorylation, dimerization and tumor suppression. Oncoscience. 2019;6:386\u20139.","journal-title":"Oncoscience"},{"key":"2744_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106013","volume":"177","author":"H Ji","year":"2022","unstructured":"Ji H, Wang W, Li X, Han X, Zhang X, Wang J, et al. p53: A double-edged sword in tumor ferroptosis. Pharm Res. 2022;177:106013.","journal-title":"Pharm Res"},{"key":"2744_CR76","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang S-J, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci USA. 2016;113:E6806\u2013E6812.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2744_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.802124","volume":"11","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Wu H, Wang F, Xu L, Yan Y, Tong X, et al. GPX7 Is Targeted by miR-29b and GPX7 knockdown enhances ferroptosis induced by erastin in glioma. Front Oncol. 2021;11:802124.","journal-title":"Front Oncol"},{"key":"2744_CR78","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41420-021-00709-4","volume":"7","author":"Q Chen","year":"2021","unstructured":"Chen Q, Wang W, Wu Z, Chen S, Chen X, Zhuang S, et al. Over-expression of lncRNA TMEM161B-AS1 promotes the malignant biological behavior of glioma cells and the resistance to temozolomide via up-regulating the expression of multiple ferroptosis-related genes by sponging hsa-miR-27a-3p. Cell Death Discov. 2021;7:311.","journal-title":"Cell Death Discov"},{"key":"2744_CR79","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1007\/s12035-022-02736-3","volume":"59","author":"C Luo","year":"2022","unstructured":"Luo C, Nie C, Zeng Y, Qian K, Li X, Wang X. LINC01564 promotes the TMZ resistance of glioma cells by upregulating NFE2L2 expression to inhibit ferroptosis. Mol Neurobiol. 2022;59:3829\u201344.","journal-title":"Mol Neurobiol"},{"key":"2744_CR80","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7150\/ijbs.66114","volume":"18","author":"S Chen","year":"2022","unstructured":"Chen S, Zhang Z, Zhang B, Huang Q, Liu Y, Qiu Y, et al. CircCDK14 promotes tumor progression and resists ferroptosis in glioma by regulating PDGFRA. Int J Biol Sci. 2022;18:841\u201357.","journal-title":"Int J Biol Sci"},{"key":"2744_CR81","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16451","volume":"11","author":"W Tie","year":"2023","unstructured":"Tie W, Ge F. Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression. PeerJ. 2023;11:e16451.","journal-title":"PeerJ"},{"key":"2744_CR82","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","volume":"33","author":"LE Pope","year":"2023","unstructured":"Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023;33:1077\u201387.","journal-title":"Trends Cell Biol"},{"key":"2744_CR83","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.7150\/thno.19988","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Mao C, Yang R, Yan B, Shi Y, Liu X, et al. EGLN1\/c-Myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes. Theranostics. 2017;7:3293\u2013305.","journal-title":"Theranostics"},{"key":"2744_CR84","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"2744_CR85","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/2211-5463.12823","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhao Y, Wang H, Zhang C, Wang M, Yang Y, et al. Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11. FEBS Open Bio. 2020;10:637\u201343.","journal-title":"FEBS Open Bio"},{"key":"2744_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1383203","volume":"15","author":"MAU Din","year":"2024","unstructured":"Din MAU, Lin Y, Wang N, Wang B, Mao F. Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets in cancer. Front Pharmacol. 2024;15:1383203.","journal-title":"Front Pharmacol"},{"key":"2744_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1564-7","volume":"10","author":"S Sui","year":"2019","unstructured":"Sui S, Zhang J, Xu S, Wang Q, Wang P, Pang D. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells. Cell Death Dis. 2019;10:331.","journal-title":"Cell Death Dis"},{"key":"2744_CR88","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1367938","volume":"2023","author":"C Zhang","year":"2023","unstructured":"Zhang C, Lu X, Liu X, Xu J, Li J, Qu T, et al. Carbonic anhydrase IX controls vulnerability to ferroptosis in gefitinib-resistant lung cancer. Oxid Med Cell Longev. 2023;2023:1367938.","journal-title":"Oxid Med Cell Longev"},{"key":"2744_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106739","volume":"191","author":"C Xu","year":"2023","unstructured":"Xu C, Jiang Z-B, Shao L, Zhao Z-M, Fan X-X, Sui X, et al. \u03b2-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer. Pharm Res. 2023;191:106739.","journal-title":"Pharm Res"},{"key":"2744_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04367-3","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Mo J, Dai J, Ye C, Cen W, Zheng X, et al. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2\/HO-1 signalling pathway in KRAS mutant colorectal cancer. Cell Death Dis. 2021;12:1079.","journal-title":"Cell Death Dis"},{"key":"2744_CR91","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","volume":"122","author":"S Han","year":"2020","unstructured":"Han S, Liu Y, Cai SJ, Qian M, Ding J, Larion M, et al. IDH mutation in glioma: molecular mechanisms and potential therapeutic targets. Br J Cancer. 2020;122:1580\u20139.","journal-title":"Br J Cancer"},{"key":"2744_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1984-4","volume":"10","author":"T-X Wang","year":"2019","unstructured":"Wang T-X, Liang J-Y, Zhang C, Xiong Y, Guan K-L, Yuan H-X. The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis. Cell Death Dis. 2019;10:755.","journal-title":"Cell Death Dis"},{"key":"2744_CR93","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1535-7163.MCT-19-0103","volume":"19","author":"X Tang","year":"2020","unstructured":"Tang X, Fu X, Liu Y, Yu D, Cai SJ, Yang C. Blockade of glutathione metabolism in IDH1-mutated glioma. Mol Cancer Ther. 2020;19:221\u201330.","journal-title":"Mol Cancer Ther"},{"key":"2744_CR94","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s42003-022-03538-y","volume":"5","author":"VTA Vo","year":"2022","unstructured":"Vo VTA, Kim S, Hua TNM, Oh J, Jeong Y. Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment. Commun Biol. 2022;5:593.","journal-title":"Commun Biol"},{"key":"2744_CR95","doi-asserted-by":"publisher","first-page":"e0221952","DOI":"10.1371\/journal.pone.0221952","volume":"14","author":"V Ravi","year":"2019","unstructured":"Ravi V, Madhankumar AB, Abraham T, Slagle-Webb B, Connor JR. Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms. PLoS One. 2019;14:e0221952.","journal-title":"PLoS One"},{"key":"2744_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0864-7","volume":"9","author":"M Buccarelli","year":"2018","unstructured":"Buccarelli M, Marconi M, Pacioni S, De Pascalis I, D\u2019Alessandris QG, Martini M, et al. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis. Cell Death Dis. 2018;9:841.","journal-title":"Cell Death Dis"},{"key":"2744_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05384-6","volume":"13","author":"Q Dang","year":"2022","unstructured":"Dang Q, Sun Z, Wang Y, Wang L, Liu Z, Han X. Ferroptosis: a double-edged sword mediating immune tolerance of cancer. Cell Death Dis. 2022;13:925.","journal-title":"Cell Death Dis"},{"key":"2744_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117298","volume":"179","author":"X Li","year":"2024","unstructured":"Li X, Li Y, Tuerxun H, Zhao Y, Liu X, Zhao Y. Firing up \u2018cold\u2019 tumors: Ferroptosis causes immune activation by improving T cell infiltration. Biomed Pharmacother. 2024;179:117298.","journal-title":"Biomed Pharmacother"},{"key":"2744_CR99","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/cac2.12487","volume":"43","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Sun L, Guo J, Ma J. The crosstalk between ferroptosis and anti-tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy. Cancer Commun. 2023;43:1071\u201396.","journal-title":"Cancer Commun"},{"key":"2744_CR100","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2016.02.016","volume":"44","author":"MP Soares","year":"2016","unstructured":"Soares MP, Hamza I. Macrophages and iron metabolism. Immunity. 2016;44:492\u2013504.","journal-title":"Immunity"},{"key":"2744_CR101","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","volume":"43","author":"K Cui","year":"2024","unstructured":"Cui K, Wang K, Huang Z. Ferroptosis and the tumor microenvironment. J Exp Clin Cancer Res. 2024;43:315.","journal-title":"J Exp Clin Cancer Res"},{"key":"2744_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04775-z","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Wang Y, Guo L, Gao W, Tang T-L, Yan M. Interaction between macrophages and ferroptosis. Cell Death Dis. 2022;13:355.","journal-title":"Cell Death Dis"},{"key":"2744_CR103","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230420","volume":"221","author":"IW Folkert","year":"2024","unstructured":"Folkert IW, Molina Arocho WA, To TKJ, Devalaraja S, Molina IS, Shoush J, et al. An iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axis. J Exp Med. 2024;221:e20230420.","journal-title":"J Exp Med"},{"key":"2744_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03034-7","volume":"19","author":"J-L Sun","year":"2021","unstructured":"Sun J-L, Zhang N-P, Xu R-C, Zhang G-C, Liu Z-Y, Abuduwaili W, et al. Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. J Transl Med. 2021;19:347.","journal-title":"J Transl Med"},{"key":"2744_CR105","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.trecan.2022.12.008","volume":"9","author":"MB Watowich","year":"2023","unstructured":"Watowich MB, Gilbert MR, Larion M. T cell exhaustion in malignant gliomas. Trends Cancer. 2023;9:270\u201392.","journal-title":"Trends Cancer"},{"key":"2744_CR106","doi-asserted-by":"publisher","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8:e001369.","journal-title":"J Immunother Cancer"},{"key":"2744_CR107","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2101769","volume":"11","author":"H Luo","year":"2022","unstructured":"Luo H, Wang X, Song S, Wang Y, Dan Q, Ge H. Targeting stearoyl-coa desaturase enhances radiation induced ferroptosis and immunogenic cell death in esophageal squamous cell carcinoma. Oncoimmunology. 2022;11:2101769.","journal-title":"Oncoimmunology"},{"key":"2744_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1025067","volume":"12","author":"W Li","year":"2022","unstructured":"Li W, Fu H, Fang L, Chai H, Gao T, Chen Z, et al. Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy. Front Oncol. 2022;12:1025067.","journal-title":"Front Oncol"},{"key":"2744_CR109","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/odi.14077","volume":"29","author":"Y-Y Zhao","year":"2023","unstructured":"Zhao Y-Y, Lian J-X, Lan Z, Zou K-L, Wang W-M, Yu G-T. Ferroptosis promotes anti-tumor immune response by inducing immunogenic exposure in HNSCC. Oral Dis. 2023;29:933\u201341.","journal-title":"Oral Dis"},{"key":"2744_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.949835","volume":"13","author":"L-G Li","year":"2022","unstructured":"Li L-G, Peng X-C, Yu T-T, Xu H-Z, Han N, Yang X-X, et al. Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage. Front Pharm. 2022;13:949835.","journal-title":"Front Pharm"},{"key":"2744_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"X Hao","year":"2022","unstructured":"Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X, et al. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2022;56:102463.","journal-title":"Redox Biol"},{"key":"2744_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203973","volume":"10","author":"B Tang","year":"2023","unstructured":"Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W, et al. Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the Anti-PD-1\/L1 response. Adv Sci. 2023;10:e2203973.","journal-title":"Adv Sci"},{"key":"2744_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109168","volume":"111","author":"S Li","year":"2022","unstructured":"Li S, Li F, Xu L, Liu X, Zhu X, Gao W, et al. TLR2 agonist promotes myeloid-derived suppressor cell polarization via Runx1 in hepatocellular carcinoma. Int Immunopharmacol. 2022;111:109168.","journal-title":"Int Immunopharmacol"},{"key":"2744_CR114","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.4049\/jimmunol.173.4.2500","volume":"173","author":"DVR Prasad","year":"2004","unstructured":"Prasad DVR, Nguyen T, Li Z, Yang Y, Duong J, Wang Y, et al. Murine B7-H3 is a negative regulator of T cells. J Immunol. 2004;173:2500\u20136.","journal-title":"J Immunol"},{"key":"2744_CR115","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.cmet.2023.09.004","volume":"35","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Liu Z, Liu G, Zhang Y, Liu S, Gan D, et al. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1. Cell Metab. 2023;35:1688\u20131703.e10.","journal-title":"Cell Metab"},{"key":"2744_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu C, Sun S, Johnson T, Qi R, Zhang S, Zhang J, et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 2021;35:109235.","journal-title":"Cell Rep"},{"key":"2744_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02175-9","volume":"23","author":"M-Q Yang","year":"2024","unstructured":"Yang M-Q, Zhang S-L, Sun L, Huang L-T, Yu J, Zhang J-H, et al. Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells. Mol Cancer. 2024;23:260.","journal-title":"Mol Cancer"},{"key":"2744_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202203659","volume":"18","author":"Y-Y Ling","year":"2022","unstructured":"Ling Y-Y, Wang W-J, Hao L, Wu X-W, Liang J-H, Zhang H, et al. Self-amplifying iridium(III) photosensitizer for ferroptosis-mediated immunotherapy against transferrin receptor-overexpressing cancer. Small. 2022;18:e2203659.","journal-title":"Small"},{"key":"2744_CR119","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1021\/acsbiomaterials.2c00950","volume":"8","author":"SD Jeong","year":"2022","unstructured":"Jeong SD, Jung B-K, Lee D, Ha J, Chang H-G, Lee J, et al. Enhanced immunogenic cell death by apoptosis\/ferroptosis hybrid pathway potentiates PD-L1 blockade cancer immunotherapy. ACS Biomater Sci Eng. 2022;8:5188\u201398.","journal-title":"ACS Biomater Sci Eng"},{"key":"2744_CR120","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1021\/acsnano.2c10893","volume":"17","author":"K Li","year":"2023","unstructured":"Li K, Xu K, He Y, Yang Y, Tan M, Mao Y, et al. Oxygen self-generating nanoreactor mediated ferroptosis activation and immunotherapy in triple-negative breast cancer. ACS Nano. 2023;17:4667\u201387.","journal-title":"ACS Nano"},{"key":"2744_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202202843","volume":"61","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Liang H, Yang R, Yang Y, Dong J, Di Y, et al. Glutathione depletion-induced activation of dimersomes for potentiating the ferroptosis and immunotherapy of \u2018Cold\u2019 tumor. Angew Chem Int Ed Engl. 2022;61:e202202843.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2744_CR122","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.7150\/thno.57803","volume":"11","author":"C-H Hsieh","year":"2021","unstructured":"Hsieh C-H, Hsieh H-C, Shih F-S, Wang P-W, Yang L-X, Shieh D-B, et al. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Theranostics. 2021;11:7072\u201391.","journal-title":"Theranostics"},{"key":"2744_CR123","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12951-022-01575-7","volume":"20","author":"Y-C Chin","year":"2022","unstructured":"Chin Y-C, Yang L-X, Hsu F-T, Hsu C-W, Chang T-W, Chen H-Y, et al. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation. J Nanobiotechnol. 2022;20:373.","journal-title":"J Nanobiotechnol"},{"key":"2744_CR124","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3892\/mmr.2024.13344","volume":"30","author":"J Wu","year":"2024","unstructured":"Wu J, Wang N. Current progress of anti\u2011PD\u20111\/PDL1 immunotherapy for glioblastoma (Review). Mol Med Rep. 2024;30:221.","journal-title":"Mol Med Rep"},{"key":"2744_CR125","doi-asserted-by":"publisher","first-page":"e004381","DOI":"10.1136\/jitc-2021-004381","volume":"10","author":"W Guo","year":"2022","unstructured":"Guo W, Wu Z, Chen J, Guo S, You W, Wang S, et al. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. J Immunother Cancer. 2022;10:e004381.","journal-title":"J Immunother Cancer"},{"key":"2744_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17380-5","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu B, Choi B, Li W, Kim D-H. Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy. Nat Commun. 2020;11:3637.","journal-title":"Nat Commun"},{"key":"2744_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1255443","volume":"14","author":"Z Lin","year":"2023","unstructured":"Lin Z, Zou S, Wen K. The crosstalk of CD8+ T cells and ferroptosis in cancer. Front Immunol. 2023;14:1255443.","journal-title":"Front Immunol"},{"key":"2744_CR128","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41420-025-02415-x","volume":"11","author":"Y Liang","year":"2025","unstructured":"Liang Y, Zhao Y, Qi Z, Li X, Zhao Y. Ferroptosis: CD8+T cells\u2019 blade to destroy tumor cells or poison for self-destruction. Cell Death Discov. 2025;11:128.","journal-title":"Cell Death Discov"},{"key":"2744_CR129","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10495-024-01988-9","volume":"29","author":"Z Mao","year":"2024","unstructured":"Mao Z, Hu Y, Zhao Y, Zhang X, Guo L, Wang X, et al. The mutual regulatory role of ferroptosis and immunotherapy in anti-tumor therapy. Apoptosis. 2024;29:1291\u2013308.","journal-title":"Apoptosis"},{"key":"2744_CR130","doi-asserted-by":"publisher","first-page":"e007180","DOI":"10.1136\/jitc-2023-007180","volume":"11","author":"H Komuro","year":"2023","unstructured":"Komuro H, Shinohara S, Fukushima Y, Demachi-Okamura A, Muraoka D, Masago K, et al. Single-cell sequencing on CD8+ TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer\/testis antigen in non-small cell lung cancer. J Immunother Cancer. 2023;11:e007180.","journal-title":"J Immunother Cancer"},{"key":"2744_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05118-6","volume":"22","author":"H Yang","year":"2024","unstructured":"Yang H, Lei Z, He J, Zhang L, Lai T, Zhou L, et al. Single-cell RNA sequencing reveals recruitment of the M2-like CCL8high macrophages in Lewis lung carcinoma-bearing mice following hypofractionated radiotherapy. J Transl Med. 2024;22:306.","journal-title":"J Transl Med"},{"key":"2744_CR132","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbrc.2018.05.064","volume":"501","author":"B Dai","year":"2018","unstructured":"Dai B, Qi N, Li J, Zhang G. Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model. Biochem Biophys Res Commun. 2018;501:871\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"2744_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02208-3","volume":"24","author":"S He","year":"2025","unstructured":"He S, Zheng L, Qi C. Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy. Mol Cancer. 2025;24:5.","journal-title":"Mol Cancer"},{"key":"2744_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Sig Transduct Target Ther. 2024;9:1\u201330.","journal-title":"Sig Transduct Target Ther"},{"key":"2744_CR135","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cytogfr.2023.08.004","volume":"75","author":"X Zhai","year":"2024","unstructured":"Zhai X, Lin Y, Zhu L, Wang Y, Zhang J, Liu J, et al. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications. Cytokine Growth Factor Rev. 2024;75:101\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2744_CR136","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.celrep.2019.10.070","volume":"29","author":"J Muri","year":"2019","unstructured":"Muri J, Thut H, Bornkamm GW, Kopf M. B1 and marginal zone B cells but not follicular B2 cells require Gpx4 to prevent lipid peroxidation and ferroptosis. Cell Rep. 2019;29:2731\u201344.e4.","journal-title":"Cell Rep"},{"key":"2744_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108381","volume":"33","author":"D Zhivaki","year":"2020","unstructured":"Zhivaki D, Borriello F, Chow OA, Doran B, Fleming I, Theisen DJ, et al. Inflammasomes within hyperactive murine dendritic cells stimulate long-lived T cell-mediated anti-tumor immunity. Cell Rep. 2020;33:108381.","journal-title":"Cell Rep"},{"key":"2744_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06503-1","volume":"15","author":"C Han","year":"2024","unstructured":"Han C, Ge M, Xing P, Xia T, Zhang C, Ma K, et al. Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells. Cell Death Dis. 2024;15:145.","journal-title":"Cell Death Dis"},{"key":"2744_CR139","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33:1001\u201312.e5.","journal-title":"Cell Metab"},{"key":"2744_CR140","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, et al. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metab. 2019;30:143\u2013156.e5.","journal-title":"Cell Metab"},{"key":"2744_CR141","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu S, Chaudhary O, Rodr\u00edguez-Morales P, Sun X, Chen D, Zappasodi R, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity. 2021;54:1561\u201377.e7.","journal-title":"Immunity"},{"key":"2744_CR142","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","volume":"629","author":"M Morotti","year":"2024","unstructured":"Morotti M, Grimm AJ, Hope HC, Arnaud M, Desbuisson M, Rayroux N, et al. PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function. Nature. 2024;629:426\u201334.","journal-title":"Nature"},{"key":"2744_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79417-9","volume":"14","author":"W Jiang","year":"2024","unstructured":"Jiang W, Xu S, Zhao M, Li C. SLC2A3 promotes head and neck squamous cancer developing through negatively regulating CD8+\u2009T cell in tumor microenvironment. Sci Rep. 2024;14:29458.","journal-title":"Sci Rep"},{"key":"2744_CR144","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.immuni.2024.08.003","volume":"57","author":"Y Ping","year":"2024","unstructured":"Ping Y, Shan J, Qin H, Li F, Qu J, Guo R, et al. PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis. Immunity. 2024;57:2122\u201339.e9.","journal-title":"Immunity"},{"key":"2744_CR145","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","volume":"9","author":"JM Drijvers","year":"2021","unstructured":"Drijvers JM, Gillis JE, Muijlwijk T, Nguyen TH, Gaudiano EF, Harris IS, et al. Pharmacologic screening identifies metabolic vulnerabilities of CD8+ T cells. Cancer Immunol Res. 2021;9:184\u201399.","journal-title":"Cancer Immunol Res"},{"key":"2744_CR146","doi-asserted-by":"publisher","DOI":"10.1172\/JCI170071","volume":"134","author":"S Chen","year":"2024","unstructured":"Chen S, Fan J, Xie P, Ahn J, Fernandez M, Billingham LK, et al. CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione\/GPX4. J Clin Invest. 2024;134:e170071.","journal-title":"J Clin Invest"},{"key":"2744_CR147","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B, Wu H, Jiang M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024;9:274.","journal-title":"Signal Transduct Target Ther"},{"key":"2744_CR148","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/cancers14071826","volume":"14","author":"D Bekric","year":"2022","unstructured":"Bekric D, Ocker M, Mayr C, Stintzing S, Ritter M, Kiesslich T, et al. Ferroptosis in hepatocellular carcinoma: mechanisms, drug targets and approaches to clinical translation. Cancers. 2022;14:1826.","journal-title":"Cancers"},{"key":"2744_CR149","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","volume":"8","author":"T Ma","year":"2022","unstructured":"Ma T, Du J, Zhang Y, Wang Y, Wang B, Zhang T. GPX4-independent ferroptosis-a new strategy in disease\u2019s therapy. Cell Death Discov. 2022;8:434.","journal-title":"Cell Death Discov"},{"key":"2744_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113524","volume":"153","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Z, Sun W, Zhang J, Xu Q, Zhou X, et al. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets. Biomed Pharmacother. 2022;153:113524.","journal-title":"Biomed Pharmacother"},{"key":"2744_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06144-w","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Zheng S, Fan Y, Tan K. Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases. Cell Death Dis. 2023;14:628.","journal-title":"Cell Death Dis"},{"key":"2744_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06180-4","volume":"23","author":"H Yang","year":"2025","unstructured":"Yang H, Zhang X, Jia Z, Wang H, Wu J, Wei X, et al. Targeting ferroptosis in prostate cancer management: molecular mechanisms, multidisciplinary strategies and translational perspectives. J Transl Med. 2025;23:166.","journal-title":"J Transl Med"},{"key":"2744_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.868639","volume":"12","author":"Q Bi","year":"2022","unstructured":"Bi Q, Sun Z-J, Wu J-Y, Wang W. Ferroptosis-mediated formation of tumor-promoting immune microenvironment. Front Oncol. 2022;12:868639.","journal-title":"Front Oncol"},{"key":"2744_CR154","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12672-022-00556-4","volume":"13","author":"WA Awuah","year":"2022","unstructured":"Awuah WA, Toufik A-R, Yarlagadda R, Mikhailova T, Mehta A, Huang H, et al. Exploring the role of Nrf2 signaling in glioblastoma multiforme. Discov Oncol. 2022;13:94.","journal-title":"Discov Oncol"},{"key":"2744_CR155","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fonc.2020.00897","volume":"10","author":"Z Hu","year":"2020","unstructured":"Hu Z, Mi Y, Qian H, Guo N, Yan A, Zhang Y, et al. A potential mechanism of temozolomide resistance in glioma-ferroptosis. Front Oncol. 2020;10:897.","journal-title":"Front Oncol"},{"key":"2744_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100985","volume":"51","author":"J Zhao","year":"2024","unstructured":"Zhao J, Ma X, Gao P, Han X, Zhao P, Xie F, et al. Advancing glioblastoma treatment by targeting metabolism. Neoplasia. 2024;51:100985.","journal-title":"Neoplasia"},{"key":"2744_CR157","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/cells13181574","volume":"13","author":"AI Cortes Ballen","year":"2024","unstructured":"Cortes Ballen AI, Amosu M, Ravinder S, Chan J, Derin E, Slika H, et al. Metabolic reprogramming in glioblastoma multiforme: a review of pathways and therapeutic targets. Cells. 2024;13:1574.","journal-title":"Cells"},{"key":"2744_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1344290","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Chen N, Ding C, Zhang H, Liu D, Liu S. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay. Front Oncol. 2024;14:1344290.","journal-title":"Front Oncol"},{"key":"2744_CR159","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s42003-020-01367-5","volume":"3","author":"J Seo","year":"2020","unstructured":"Seo J, Jeong D-W, Park J-W, Lee K-W, Fukuda J, Chun Y-S. Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Commun Biol. 2020;3:638.","journal-title":"Commun Biol"},{"key":"2744_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21:47.","journal-title":"Mol Cancer"},{"key":"2744_CR161","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s44318-024-00176-4","volume":"43","author":"MA Banu","year":"2024","unstructured":"Banu MA, Dovas A, Argenziano MG, Zhao W, Sperring CP, Cuervo Grajal H, et al. A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma. EMBO J. 2024;43:4492\u2013521.","journal-title":"EMBO J"},{"key":"2744_CR162","doi-asserted-by":"publisher","first-page":"74630","DOI":"10.18632\/oncotarget.11858","volume":"7","author":"T Sehm","year":"2016","unstructured":"Sehm T, Rauh M, Wiendieck K, Buchfelder M, Ey\u00fcpoglu IiY, Savaskan NE. Temozolomide toxicity operates in a xCT\/SLC7a11 dependent manner and is fostered by ferroptosis. Oncotarget. 2016;7:74630\u201347.","journal-title":"Oncotarget"},{"key":"2744_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134777","volume":"278","author":"MD Caverzan","year":"2024","unstructured":"Caverzan MD, Ibarra LE. Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations. Int J Biol Macromol. 2024;278:134777.","journal-title":"Int J Biol Macromol"},{"key":"2744_CR164","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","volume":"12","author":"G Lei","year":"2021","unstructured":"Lei G, Mao C, Yan Y, Zhuang L, Gan B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 2021;12:836\u201357.","journal-title":"Protein Cell"},{"key":"2744_CR165","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/ph18030325","volume":"18","author":"D Sant\u2019Angelo","year":"2025","unstructured":"Sant\u2019Angelo D, Descamps G, Lecomte V, Stanicki D, Penninckx S, Dragan T, et al. Therapeutic approaches with iron oxide nanoparticles to induce ferroptosis and overcome radioresistance in cancers. Pharmaceuticals. 2025;18:325.","journal-title":"Pharmaceuticals"},{"key":"2744_CR166","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/acschembio.9b00939","volume":"15","author":"LF Ye","year":"2020","unstructured":"Ye LF, Chaudhary KR, Zandkarimi F, Harken AD, Kinslow CJ, Upadhyayula PS, et al. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem Biol. 2020;15:469\u201384.","journal-title":"ACS Chem Biol"},{"key":"2744_CR167","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.3390\/ijms23136879","volume":"23","author":"I de Souza","year":"2022","unstructured":"de Souza I, Ramalho MCC, Guedes CB, Osawa IYA, Monteiro LKS, Gomes LR, et al. Ferroptosis modulation: potential therapeutic target for glioblastoma treatment. Int J Mol Sci. 2022;23:6879.","journal-title":"Int J Mol Sci"},{"key":"2744_CR168","doi-asserted-by":"publisher","first-page":"e003430","DOI":"10.1136\/jitc-2021-003430","volume":"9","author":"R Demuynck","year":"2021","unstructured":"Demuynck R, Efimova I, Naessens F, Krysko DV. Immunogenic ferroptosis and where to find it?. J Immunother Cancer. 2021;9:e003430.","journal-title":"J Immunother Cancer"},{"key":"2744_CR169","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163447","volume":"133","author":"VA Arrieta","year":"2023","unstructured":"Arrieta VA, Dmello C, McGrail DJ, Brat DJ, Lee-Chang C, Heimberger AB, et al. Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment. J Clin Invest. 2023;133:e163447.","journal-title":"J Clin Invest"},{"key":"2744_CR170","doi-asserted-by":"publisher","first-page":"vii80","DOI":"10.1093\/neuonc\/noac209.305","volume":"24","author":"BS Skeie","year":"2022","unstructured":"Skeie BS, Bragstad S, Sarowar S, Behbahani M, Filippi C, Knisely J, et al. CTNI-40. Phase I trial of sulfasalazine combined with stereotactic radiosurgery for recurrent glioblastoma: study protocol for NCT04205357. Neuro Oncol. 2022;24:vii80\u2013vii81.","journal-title":"Neuro Oncol"},{"key":"2744_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z. GPX4, ferroptosis, and diseases. Biomed Pharmacother. 2024;174:116512.","journal-title":"Biomed Pharmacother"},{"key":"2744_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841418","volume":"12","author":"H Kram","year":"2022","unstructured":"Kram H, Prokop G, Haller B, Gempt J, Wu Y, Schmidt-Graf F, et al. Glioblastoma relapses show increased markers of vulnerability to ferroptosis. Front Oncol. 2022;12:841418.","journal-title":"Front Oncol"},{"key":"2744_CR173","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"key":"2744_CR174","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392.","journal-title":"Nature"},{"key":"2744_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103220","volume":"73","author":"Z Miao","year":"2024","unstructured":"Miao Z, Xu L, Gu W, Ren Y, Li R, Zhang S, et al. A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma. Redox Biol. 2024;73:103220.","journal-title":"Redox Biol"},{"key":"2744_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107115","volume":"202","author":"Y Hai","year":"2024","unstructured":"Hai Y, Fan R, Zhao T, Lin R, Zhuang J, Deng A, et al. A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression. Pharm Res. 2024;202:107115.","journal-title":"Pharm Res"},{"key":"2744_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08559-0","volume":"21","author":"Y Hong","year":"2021","unstructured":"Hong Y, Lin M, Ou D, Huang Z, Shen P. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma. BMC Cancer. 2021;21:831.","journal-title":"BMC Cancer"},{"key":"2744_CR178","first-page":"179","volume":"13","author":"C Wang","year":"2023","unstructured":"Wang C, Wen L, Wang K, Wu R, Li M, Zhang Y, et al. Visualization of ferroptosis in brain diseases and ferroptosis-inducing nanomedicine for glioma. Am J Nucl Med Mol Imaging. 2023;13:179\u201394.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2744_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217392","volume":"611","author":"A Carlos","year":"2025","unstructured":"Carlos A, Mendes M, Cruz MT, Pais A, Vitorino C. Ferroptosis driven by nanoparticles for tackling glioblastoma. Cancer Lett. 2025;611:217392.","journal-title":"Cancer Lett"},{"key":"2744_CR180","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ijrobp.2020.12.019","volume":"110","author":"H-J Wei","year":"2021","unstructured":"Wei H-J, Upadhyayula PS, Pouliopoulos AN, Englander ZK, Zhang X, Jan C-I, et al. Focused ultrasound-mediated blood-brain barrier opening increases delivery and efficacy of etoposide for glioblastoma treatment. Int J Radiat Oncol Biol Phys. 2021;110:539\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2744_CR181","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0076-6879(09)65018-7","volume":"465","author":"MT Krauze","year":"2009","unstructured":"Krauze MT, Forsayeth J, Yin D, Bankiewicz KS. Convection-enhanced delivery of liposomes to primate brain. Methods Enzymol. 2009;465:349\u201362.","journal-title":"Methods Enzymol"},{"key":"2744_CR182","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn4306","volume":"10","author":"X Wang","year":"2024","unstructured":"Wang X, Sun Q, Liu T, Lu H, Lin X, Wang W, et al. Single-cell multi-omics sequencing uncovers region-specific plasticity of glioblastoma for complementary therapeutic targeting. Sci Adv. 2024;10:eadn4306.","journal-title":"Sci Adv"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02744-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02744-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02744-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:13:19Z","timestamp":1759849999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02744-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":182,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02744-x","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}